Literature DB >> 2660790

Tissue specific distribution, clearance and vascular effects of endothelin in the pig.

J Pernow1, A Hemsén, J M Lundberg.   

Abstract

Endothelin-like immunoreactivity (-LI) was detected in the kidney, spleen, skeletal muscle, lung and in plasma of the pig. The highest tissue levels were found in the lung (1.5 +/- 0.07 pmol/g) and the lowest in the muscle (0.08 +/- 0.02 pmol/g). I.v. infusion of endothelin (20 pmol/kg/min for 20 min) increased plasma endothelin-LI from 18 +/- 3 to 628 +/- 109 pM and renal, splenic and femoral vascular resistance by 570, 430 and 50%, respectively. There was a close correlation between the increase in plasma endothelin-LI and the vasoconstrictor effects. During the infusion 92, 82 and 76% of arterial endothelin-LI was removed by the kidney, spleen and hindlimb, respectively, whereas there was no clearance over the lung or degradation in plasma. After the infusion, arterial endothelin-LI decreased with a half life of 77 s, while the renal and splenic vasoconstriction persisted for 60 min. Characterization by reversed phase HPLC revealed that endothelin-LI in plasma and tissue co-eluted with synthetic endothelin. It is concluded that endothelin has tissue specific distribution, clearance and vascular effects in the pig.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660790     DOI: 10.1016/0006-291x(89)92648-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Endothelin mediated nitric oxide effects in ischemia--reperfusion associated with pancreas transplantation.

Authors:  G Hotter; F Pi; C Sanz; C Peralta; N Prats; E Gelpi; F Badosa; L Fernández-Cruz; J Roselló-Catafau
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

2.  Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo.

Authors:  Audrey V Gourine; Audrey I Molosh; Dmitry Poputnikov; Aliaksandr Bulhak; Per-Ove Sjöquist; John Pernow
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Nitric oxide modulates renal vasoconstrictor effect of endothelin-1 in conscious lambs.

Authors:  Francine G Smith; Liesbeth van der Velde; Alp Sener
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

4.  Release of endothelial mediators and sympathetic transmitters at different coronary flow rates in rabbit hearts.

Authors:  A Wennmalm; G Benthin; E Karwatowska-Prokopczuk; J Lundberg; A S Petersson
Journal:  J Physiol       Date:  1991-04       Impact factor: 5.182

5.  Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.

Authors:  E Weitzberg; A Hemsén; A Rudehill; A Modin; M Wanecek; J M Lundberg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  Regional haemodynamic responses to intravenous and intraarterial endothelin-1 and big endothelin-1 in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression.

Authors:  J D Firth; P J Ratcliffe
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Circulating endothelin in children with congenital heart disease.

Authors:  I Adatia; S G Haworth
Journal:  Br Heart J       Date:  1993-03

9.  Endothelin-1 in patients with complicated and uncomplicated myocardial infarction.

Authors:  P Lechleitner; N Genser; J Mair; J Maier; E Artner-Dworzak; F Dienstl; B Puschendorf
Journal:  Clin Investig       Date:  1992-12

10.  Thromboxane modulates endothelial permeability.

Authors:  J M Klausner; S Abu-Abid; J S Alexander; R Hanshke-Mineau; G Goldman; N Morel; C R Valeri; D Shepro; H B Hechtman
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.